statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo (vadadustat) Tablets

Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo (vadadustat) Tablets Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass...

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire...

Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer

Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR...

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswire CAMBRIDGE, Mass., May 23, 2024...

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference PR Newswire CAMBRIDGE, Mass...

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights PR...

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass., May...

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Volume	1.14M
52-Wk High	$2.48
52-Wk Low	$0.7801

AKBA Akebia Therapeutics Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals